Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Maraganore leaves Alnylam with an eye for science, a heart for access

An exit interview with the outgoing CEO of Alnylam

December 2, 2021 6:16 AM UTC

As he readies to leave Alnylam, CEO John Maraganore’s legacy will be as much about pushing the envelope on innovative pricing models as creating drugs using an entirely new modality. 

Wednesday’s announcement that Maraganore is joining Arch Venture Partners will mix the two. He has centered his career on building a company out of what was at the time an edgy discovery, and remains passionate about new modalities. At the same time, his heavy focus on access means value-based pricing models will likely permeate his influence on the companies he invests in. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Alnylam Pharmaceuticals Inc.